Clinical trial

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

NCT06694935

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-01-06

PhasePHASE1

Study timeline

Study start (actual)2025-01-06Date precision: day

Registry last updated2025-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Non-Alcoholic Fatty Liver Disease (NAFLD)unresolved

Interventions

QX1206DRUG

Sponsors & collaborators

1Globe Health Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06694935 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.